has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year, Bloomberg News reported on Tuesday.
The company submitted a report to the U.S. Food and Drug Administration and other regulators after identifying the root cause for the presence of a nitrosamine called NTTP in certain batches of the drugs, according to theNTTP belongs to the nitrosamine class of compounds, some of which are classified as probable or possible human carcinogens, based on laboratory tests, according to the FDA.Merck did not immediately respond to a Reuters request for comment.
The FDA said in August certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and Janumet, wereFor the nine month ended September, Januvia and Janumet posted sales of $2.25 billion and $1.35 billion, respectively.
_theOutpost_ Why now! Was a killing quota achieved ? Anyone?
Must be this chemical doesn’t conform to WEF requirements
Here's your life-saving drug. Oh by the way it causes cancer. Oops, we said that out loud. We'll remove the cancer-causing ingredients.
Good idea! Master stroke!